Special blood products for patients needing specialized blood transfusions.

Ended Awarded

Contract number
HT009023FG0510017
Awardee
Awarding agency
Obligated
$25,146

Award facts

Contract value 100% obligated
$25,145.59 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
AC32 National Defense R&D Services; Defense-Related Activities; Applied Research
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Washington, DC 20006, USA

Award details come from SAM.gov/FPDS.

Quick answers

Who was awarded contract HT009023FG0510017?

HT009023FG0510017 was awarded to The American National Red Cross by Defense Health Agency (Department of Defense) on May 2, 2023.

How much is contract HT009023FG0510017 worth?

The government has obligated $25,146 on HT009023FG0510017.

Is contract HT009023FG0510017 an order under another contract?

Yes. HT009023FG0510017 is a BPA call under HT001418A0029, a blanket purchase agreement.

Was contract HT009023FG0510017 competed?

The extent of competition for HT009023FG0510017 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award